Interventions to prevent obesity in children aged 2 to 4 years old

预防2至4岁儿童肥胖的干预措施

阅读:1

Abstract

This is a protocol for a Cochrane Review (intervention). The objectives are as follows: The overall aim of the review is to determine the effectiveness of interventions to prevent obesity in two‐ to four‐year‐old children. The four objectives are:  1. to evaluate the effects of interventions that aim to modify dietary intake on changes in zBMI score, BMI and serious adverse events among children;  2. to evaluate the effects of interventions that aim to modify physical activity, sedentary behaviour, sleep, play or structured exercise or a combination of these on changes in zBMI score, BMI and serious adverse events among children;  3. to evaluate the combined effects of interventions that aim to modify both dietary intake and physical activity/movement behaviours on changes in zBMI score, BMI and serious adverse events among children;  4. to compare the effects of interventions that aim to modify dietary interventions with those that aim to modify physical activity/movement behaviours on changes in zBMI score, BMI and serious adverse events among children The secondary objectives are designed to explore if, how, and why the effectiveness of interventions on zBMI/BMI varies depending on the following PROGRESS factors. Place of residence. Race/ethnicity/culture/language. Occupation. Gender/sex. Religion. Education. Socioeconomic status. Social capital. The PROGRESS acronym is intended to ensure that there is explicit consideration for health inequity, the unfair difference in disease burden, when conducting research and adapting research evidence to inform the design of new interventions (O'Neill 2014). The PROGRESS acronym describes factors that contribute to health inequity. Recent work on race and religion in the UK suggests that consideration of these factors is critical to the design of new interventions (Rai 2019). We will also collect, from RCTs, information about the costs of interventions, so that policymakers can use the review as a source of information from which they may prepare cost‐effectiveness analyses.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。